Login / Signup

Adaptive designs for clinical trials have potential advantages, but statistical challenges lurk!

Serigne N LôJohn F Thompson
Published in: The British journal of dermatology (2021)
Keyphrases
  • clinical trial
  • phase ii
  • human health
  • open label
  • risk assessment
  • climate change